All human cancer cells tested responded to PKI-587 treatment in a similar manner, i.e., time-dependent increases in the TRIM21 mRNA and protein levels, accompanied by decreased total G6PD levels, which are independent of p53 and MYC status (Fig. 4g). Here, TRIM21 is linked to cancer.